Amgen Inc

2026. g. 12. jūn. 19:51 UTC

Amgen Inc. is reassessing data on Tavneos amid FDA scrutiny. Shares are higher as the company challenges the proposal to withdraw the drug's approval.

2026. g. 11. jūn. 23:06 UTC

Amgen engages Duke Clinical Research Institute to reassess Tavneos data amid FDA concerns, with shares trading higher in after-market hours.

2026. g. 10. jūn. 23:51 UTC

Amgen Inc. shares declined in after-market trading, continuing a trend of lower daily closes amid rising Treasury yields and weakness in technology stocks.

2026. g. 9. jūn. 19:56 UTC

Amgen Inc. shares are lower as Goldman Sachs cuts its price target to $389 from $425 amid an IRS audit disclosure affecting financial outlook.

2026. g. 8. jūn. 20:06 UTC

Amgen Inc. shares are lower today after presenting Phase 3 trial results showing Repatha's effectiveness in reducing cardiovascular event risk in high-risk diabetes patients.

2026. g. 5. jūn. 23:01 UTC

Amgen Inc shares are lower in after-market trading amid a broader equity sell-off following stronger-than-expected U.S. non-farm payroll data.

2026. g. 4. jūn. 23:51 UTC

Amgen will present at the Goldman Sachs Global Healthcare Conference on June 9, 2026. Shares are trading higher in after-market hours.

2026. g. 3. jūn. 23:41 UTC

Amgen Inc shares are higher in after-market trading, supported by gains in the Biotechnology sub-sector and strong performance above its 20-day moving average.

2026. g. 2. jūn. 23:02 UTC

Amgen Inc. shares are lower in after-market trading, continuing a trend of declines over the last three sessions and remaining below the 20-day moving average.

2026. g. 1. jūn. 20:02 UTC

Amgen Inc. shares are lower today, dropping below Friday's close and nearing the lower end of their one-month trading range. No specific news was identified.

2026. g. 29. maijs 20:06 UTC

Amgen Inc's shares are higher today, reflecting a slight gain since Thursday's close. The stock remains stable within its one-month trading range.

2026. g. 28. maijs 23:56 UTC

Amgen Inc's shares are higher in after-market hours, maintaining stability above the 20-day moving average and within the one-month trading range.

2026. g. 27. maijs 23:01 UTC

Amgen Inc shares are higher in after-market trading, influenced by broader market dynamics, including declining US Treasury yields and inflation concerns.

2026. g. 26. maijs 19:56 UTC

Amgen Inc. shares are lower as rising bond yields reflect inflationary pressures. Analysts maintain a positive outlook on the company's drug pipeline and capital allocation.

2026. g. 22. maijs 20:06 UTC

Amgen Inc. is trading higher amid scrutiny of its rare disease therapy, Tavneos, linked to patient deaths and regulatory restrictions on new prescriptions.

2026. g. 21. maijs 19:13 UTC

Amgen Inc shares rose after Japan allowed new prescriptions for a rare-disease drug, reversing a previous recommendation linked to reported deaths.

2026. g. 20. maijs 19:51 UTC

Amgen Inc. shares are higher following the appointment of Thomas Dittrich as CFO and strong revenue growth of 12.3% over the past two years.

2026. g. 19. maijs 20:03 UTC

Amgen Inc. shares are trading higher as analysts express optimism about revenue growth through 2027, despite a price target reduction to $427.

2026. g. 18. maijs 19:52 UTC

Amgen Inc shares are lower as safety concerns over Tavneos intensify. Kissei Pharmaceutical advised caution after reports of 20 deaths linked to the drug.

2026. g. 15. maijs 23:26 UTC

Amgen Inc shares are higher in after-market trading, despite social media concerns over recent decisions and a warning from Kissei Pharmaceutical regarding a rare drug.

2026. g. 14. maijs 19:16 UTC

Amgen shares are lower as Piper Sandler cuts price target to $427 from $432. The stock is trading within its one-month range.

2026. g. 13. maijs 23:02 UTC

Amgen Inc. shares are trading lower in after-market hours, following unusual activity earlier in the session and remaining below the 20-day moving average.

2026. g. 12. maijs 19:51 UTC

Amgen's stock rises today amid a strong Biotechnology sector. It remains below its 20-day moving average, reflecting significant intraday fluctuations.

2026. g. 11. maijs 19:56 UTC

Amgen Inc is trading lower, reflecting broader biotech sector sentiment. The stock remains below its 20-day moving average, indicating ongoing market weakness.

2026. g. 8. maijs 19:56 UTC

Amgen shares are trading higher today amid sector challenges. The company will present at the Bank of America Healthcare Conference, discussing its innovative pipeline.

2026. g. 7. maijs 23:56 UTC

Amgen to present at Bank of America Healthcare Conference. Shares slightly increased in after-hours trading, remaining near one-month lows.

2026. g. 6. maijs 20:06 UTC

Amgen Inc trades higher today, reflecting positive market sentiment. This rise occurs alongside notable gains in Regeneron Pharmaceuticals and the Dow Jones Index.

2026. g. 5. maijs 23:31 UTC

Amgen slightly recovers in after-hours trading. The stock remains near its one-month low, amidst a slowdown in U.S. service sector activity affecting market sentiment.

2026. g. 4. maijs 23:06 UTC

Amgen sees after-hours decline amid mixed economic data. Geopolitical developments and rising energy costs contribute to market sentiment.